LobbyingVifor Fresenius Medical Care Renal Pharma lobbying by quarter
Vifor Fresenius Medical Care Renal Pharma's latest lobbying report covers Q4 2025, at under $5,000. Its first report covers Q2 2023; the issues it reports most are Health Issues and Medicare/Medicaid.
Vifor Fresenius Medical Care Renal Pharma
- Latest quarter
- No record
- Q3 2026 · 0 reports
- Last 12 months
- $0
- Last 4 quarters
- vs last quarter
- No record
- Q3 2026 against the quarter before
- First report
- Q2 2023
- The first quarter a report named it
Lobbying by quarter
| Quarter | Amount | Reports |
|---|---|---|
| Q2 2023 | $40K | 1 |
| Q3 2023 | $40K | 1 |
| Q4 2023 | $40K | 1 |
| Q1 2024 | $40K | 1 |
| Q2 2024 | $40K | 1 |
| Q3 2024 | $50K | 1 |
| Q4 2024 | $50K | 1 |
| Q1 2025 | $50K | 1 |
| Q2 2025 | $50K | 1 |
| Q3 2025 | $0 | 1 |
| Q4 2025 | $0 | 1 |
| Q1 2026 | $0 | 0 |
| Q2 2026 | $0 | 0 |
| Q3 2026 | $0 | 0 |
By issue
- Health issues$200K · 9 reports
- Medicare and Medicaid$200K · 9 reports
An issue's amount splits each report's amount equally over the issues the report lists.
Who was lobbied
- HOUSE OF REPRESENTATIVES9 reports
- SENATE9 reports
Firms it paid
| Firm | ||
|---|---|---|
| Crossroads Strategies | $400K | 11 quarters |
Former officials lobbying for it
No lobbyist with a covered position.
Lobbying reports
| Filed by | ||
|---|---|---|
| 25/12/22for Q4 2025 | Crossroads Strategies | Under $5,000 |
| 25/10/19for Q3 2025 | Crossroads Strategies | Under $5,000 |
| 25/07/20for Q2 2025 | Crossroads Strategies | $50K |
| 25/04/21for Q1 2025 | Crossroads Strategies | $50K |
| 25/01/19for Q4 2024 | Crossroads Strategies | $50K |
| 24/10/20for Q3 2024 | Crossroads Strategies | $50K |
| 24/07/22for Q2 2024 | Crossroads Strategies | $40K |
| 24/04/22for Q1 2024 | Crossroads Strategies | $40K |
| 24/01/22for Q4 2023 | Crossroads Strategies | $40K |
| 23/10/20for Q3 2023 | Crossroads Strategies | $40K |
| 23/07/20for Q2 2023 | Crossroads Strategies | $40K |
| 23/07/13for Q2 2023 | Crossroads Strategies | Under $5,000 |